Skip to content

Cromolyn Detection of Silent Aspiration

Development and Validation of Test for Gastro-esophageal Reflux and Aspiration

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01841307
Enrollment
16
Registered
2013-04-26
Start date
2015-07-31
Completion date
2017-09-30
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux, Respiratory Aspiration, Idiopathic Pulmonary Fibrosis, Lung Transplantation

Brief summary

The overall purpose of this project is to develop and validate a simple, non-invasive method to detect aspiration of gastro-intestinal fluid into the respiratory tract. In the inpatient setting, the investigators will compare the quantity of cromolyn detected in urine collected overnight after 4 ingestions (at 2h intervals) of a 200 mL of a 1mg/mL solution of cromolyn sodium, by 5 healthy control subjects and 5 patients (3-6 with pulmonary fibrosis; and 3-6 either awaiting or recently undergone lung transplantation) with clinical and laboratory evidence of GER (gastroesophageal reflux) with microaspiration. In the outpatient setting, the investigators will compare the quantity of cromolyn detected in urine collected overnight after 1 ingestions (at 4h intervals) of a 200 mL of a 1mg/mL solution of cromolyn sodium, by 10 patients (3-6 with pulmonary fibrosis; and 3-6 either awaiting or recently undergone lung transplantation) with clinical and laboratory evidence of GER (gastroesophageal reflux) with microaspiration.

Interventions

Sponsors

Aradign Corportation
CollaboratorUNKNOWN
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy participants * Adult non-smokers * Females only - negative urine pregnancy test Lung transplant patients * Adult patients awaiting (or recently undergone) - lung transplant * Evidence of gastro-esophageal reflux with probable recurrent aspiration * Females only - negative urine pregnancy test Idiopathic pulmonary fibrosis patients * Adult patients currently enrolled in on-going University of California, San Francisco study of prevalence of recurrent GER with aspiration in idiopathic pulmonary fibrosis * Evidence of gastro-esophageal reflux with probable recurrent aspiration * Females only - negative urine pregnancy test

Exclusion criteria

Healthy participants * History of dysphagia * GER * Recurrent cough * Asthma * Pneumonia after childhood * Sleep impairment * Use of drugs or alcohol impairing consciousness * Impaired gag reflex on physical examination * Any other significant medical illness (e.g., morbid obesity, diabetes, neurologic disease, etc.) that in the opinion of the investigator could affect the clinical features measured, responses to the therapies to be given in this study, or risks of participating in the study * Greater than 5 pack years lifetime smoking history * History of intolerance or allergy to cromolyn sodium Lung transplant patients * History of intolerance or allergy to cromolyn sodium * History of Nissen fundoplication IPF patients * History of intolerance or allergy to cromolyn sodium * History of Nissen fundoplication

Design outcomes

Primary

MeasureTime frame
Total cromolyn in urine collected overnightCollected overnight (6 hours)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026